Clinical Trial Details
| Trial ID: | L5933 |
| Source ID: | NCT05663736 |
| Associated Drug: | Gemigliptin |
| Title: | Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Ejection Fraction |
| Interventions: | DRUG: Gemigliptin|DRUG: Glimepiride |
| Outcome Measures: | Primary: HbA1c, Glycated hemoglobin, 24 weeks | Secondary: Ejection fraction, Cardiac function, 24 weeks|E/e', Cardiac systolic function, 24 weeks|LV mass index, Cardiac function, 24 weeks|LV end-diastolic volumn, Cardiac function, 24 weeks|NT-proBNP, Cardiac biomarker, 24 weeks|hsCRP, Cardiac biomarker, 24 weeks|Adiponectin, Metabolic biomarker, 24 weeks|Resistin, Metabolic biomarker, 24 weeks|Troponin I, Metabolic biomarker, 24 weeks|CK-MB, Metabolic biomarker, 24 weeks |
| Sponsor/Collaborators: | Sponsor: Seoul National University Bundang Hospital |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 80 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2020-01-01 |
| Completion Date: | 2023-12-31 |
| Results First Posted: | |
| Last Update Posted: | 2023-03-08 |
| Locations: | Seoul National University Bundang Hospital, Seongnam, Gyeonggi, 463-707, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT05663736 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|